The UK government has asked a consortium of pension providers to explore creating a £1 billion science and technology scale-up fund intended to invest in high‑growth companies emerging from Britain’s research base.
Ambition to link long-term capital with research strengths
Ministers say the proposed UK Scale‑up Fund would enable businesses to expand while delivering “strong long-term returns” for pension savers. The National Centre for Universities and Business (NCUB) described the move as an “encouraging step”, emphasising the need to match patient capital with the country’s “outstanding research and innovation strengths”.
Joe Marshall, chief executive of the NCUB, said the plan shows what is possible when government, industry and investors co‑operate. He added that no single institution can deliver the outcomes alone and urged universities, businesses, investors and government to play complementary roles in building a stronger scale‑up ecosystem.
“Success will depend on connecting long-term investment with the UK’s outstanding research and innovation strengths,” said Joe Marshall.
Policy context and pensions
The proposal builds on earlier efforts to encourage pension funds to invest more in productive assets. The government points to the Mansion House pension reforms introduced under the previous administration, which aimed to channel retirement savings into companies and other growth opportunities. Mobilising pension capital has been a recurrent theme in policy debates about financing innovation and regional development.
Campaigners and industry groups have amplified calls for pension mobilisation. A recent life sciences sector roundtable urged the government to unlock £500 million from pension funds for the sector in 2028, highlighting the acute capital needs of companies seeking to scale.
Regional growth and political framing
Andy Burnham, the prime minister, has made place‑based growth a central part of his agenda and framed the fund as a mechanism to “help unlock good growth in every postcode”. The NCUB also suggested the fund could generate notable benefits for regions that have been left behind by previous waves of investment, offering a way to spread the gains from research commercialisation beyond the established tech clusters.
Practical considerations and uncertainty
At this exploratory stage, the success of the proposal depends on the willingness of pension providers to commit capital and the design of the vehicle that would invest in often risky, early‑stage science and technology companies. The government has proposed a consortium model, but details on governance, risk sharing, co‑investment requirements and regional targeting have yet to be published.
Analysts will focus on several practical questions as plans progress:
- How pension funds’ fiduciary duties will be reconciled with the higher risk profile of scale‑up investments.
- What co‑investment or de‑risking measures (such as guarantees or first‑loss capital) might be offered to attract pension capital.
- Whether the fund will include explicit regional allocation criteria to address levelling‑up commitments.
Backers argue that a well‑designed fund could provide long‑term returns for savers while addressing a chronic shortage of growth capital for science‑intensive firms. Critics may question whether public policy should favour a particular financing channel and whether it can overcome the cultural and risk‑adjusted return barriers that have historically deterred pension investment in venture‑style opportunities.
| Figure | Context |
|---|---|
| £1 billion | Proposed size of the UK Scale‑up Fund under exploration |
| £500 million | Sum called for by a life sciences roundtable to be mobilised from pensions for 2028 |
If the consortium concludes the idea is viable, the next steps will include detailed fund design, agreement on roles between public and private partners, and the establishment of legal and governance structures to allow pension trustees to commit capital. Observers will watch closely to see whether this initiative becomes a template for channelling long‑term savings into the UK’s science and technology scale‑up pipeline.
The proposal underlines a broader policy challenge: translating the UK’s research strengths into commercially successful companies at scale. The government’s exploration of the fund is a concrete attempt to bridge that gap, but its ultimate impact will depend on the finer details of execution and the appetite of institutional investors to engage with high‑risk, high‑return innovation opportunities.
